R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.

J Pathol · 2022 · PMC9825844 · PMID 36106661

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Compared with Rspo3 inv ;MMTV‐ Wnt1 mice that overexpress the Wnt1 transgene only ( n = 49), there was no significant difference in tumor‐free survival ( p = 0.06), despite a slight trend towards reduced survival (Figure 5A ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.